Toward Accurate Relative Energy Predictions of the Bioactive Conformation of Drugs

被引:64
作者
Butler, Keith T. [1 ,2 ]
Luque, F. Javier [1 ,2 ]
Barril, Xavier [1 ,2 ]
机构
[1] Univ Barcelona, Inst Biomed, Barcelona, Spain
[2] Univ Barcelona, Fac Farm, Dept Fisicoquim, E-08028 Barcelona, Spain
关键词
ligand conformation; bioactive conformation; T/B constraints; B-factor constraints; flat-bottom constraints; quantum mechanics; continuum solvation models; geometry of nonstandard residues; LIGAND; MODEL; REFINEMENT; PARAMETERS; PENALTIES; MOBILITY; BINDING; CHAIN;
D O I
10.1002/jcc.21087
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Quantifying the relative energy of a ligand in its target-bound state (i.e. the bioactive conformation) is essential to understand the process of molecular recognition, to optimize the potency of bioactive molecules and to increase the accuracy of structure-based drug design methods. This is. nevertheless, Seriously hampered by two interrelated issues, namely the difficulty in carrying out an exhaustive sampling of the conformational space and the shortcomings of the energy functions, Usually based on parametric methods of limited accuracy. Matters are further complicated by the experimental uncertainty on the atomic coordinates, which precludes a univocal definition of the bioactive conformation. In this article we investigate the relative energy of bioactive conformations introducing two major improvements over previous Studies: the use sophisticated QM-based methods to take into account hot the internal energy of the ligand and the solvation effect, and the application of physically meaningful constraints to refine the bioactive conformation. On a set of 99 drug-like molecules, we find that, contrary to previous observations. two thirds of bioactive conformations lie within 0.5 kcal mol(-1) of a local minimum, With penalties above 2.0 kcal mol(-1) being generally attributable to structural determination inaccuracies. The methodology herein described opens the door to obtain quantitative estimates of the energy of bioactive conformations and call be used both as an aid in refining crystallographic structures and as a tool in drug discovery. (C) 2008 Wiley Periodicals, Inc. J Comput Chem 30: 601-610, 2009
引用
收藏
页码:601 / 610
页数:10
相关论文
共 38 条
[1]   Incorporating protein flexibility into docking and structure-based drug design [J].
Barril, Xavier ;
Fradera, Xavier .
EXPERT OPINION ON DRUG DISCOVERY, 2006, 1 (04) :335-349
[2]  
Barril Xavier, 2006, Mol Biosyst, V2, P660, DOI 10.1039/b613461k
[3]   Ligand preorganization may be accompanied by entropic penalties in protein-ligand interactions [J].
Benfield, Aaron P. ;
Teresk, Martin G. ;
Plake, Hilary R. ;
DeLorbe, John E. ;
Millspaugh, Laura E. ;
Martin, Stephen F. .
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2006, 45 (41) :6830-6835
[4]   The Protein Data Bank [J].
Berman, HM ;
Westbrook, J ;
Feng, Z ;
Gilliland, G ;
Bhat, TN ;
Weissig, H ;
Shindyalov, IN ;
Bourne, PE .
NUCLEIC ACIDS RESEARCH, 2000, 28 (01) :235-242
[5]   Basic ideas for the correction of semiempirical methods describing H-bonded systems [J].
Bernal-Uruchurtu, MI ;
Ruiz-López, MF .
CHEMICAL PHYSICS LETTERS, 2000, 330 (1-2) :118-124
[6]   Conformational energy penalties of protein-bound ligands [J].
Bostrom, J ;
Norrby, PO ;
Liljefors, T .
JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN, 1998, 12 (04) :383-396
[7]   Correlation between side chain mobility and conformation in protein structures [J].
Carugo, O ;
Argos, P .
PROTEIN ENGINEERING, 1997, 10 (07) :777-787
[8]  
*CHEM COMP GROUP, 2006, VERS 2006 08
[9]   Application and limitations of X-ray crystallographic data in structure-based ligand and drug design [J].
Davis, AM ;
Teague, SJ ;
Kleywegt, GJ .
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2003, 42 (24) :2718-2736
[10]   Fast calculation of molecular polar surface area as a sum of fragment-based contributions and its application to the prediction of drug transport properties [J].
Ertl, P ;
Rohde, B ;
Selzer, P .
JOURNAL OF MEDICINAL CHEMISTRY, 2000, 43 (20) :3714-3717